Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study
Open Access
- 9 January 2018
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 19 (1) , 9
Abstract
Chondrosarcoma is the second most common primary malignant bone tumor. Because of their heterogeneity, with differences in invasive and metastatic behavior, it is important to identify biological markers that will allow for a more accurate estimation of prognosis in patients with these tumors. Matrix metalloproteinases (MMP) play a crucial role in tumor progression, invasion and metastasis. The mechanism of tumor progression dependent of MMPs is complex and influences malignant transformation, angiogenesis and tumor growth at the primary and metastatic sites. The purpose of this study was to investigate immunohistochemicaly the influence of MMP-1, MMP-3, MMP-9 and MMP-13 expression on prognostic parameter in chondrosarcoma. We investigated tissue samples of 28 patients with chondrosarcoma. Immunohistochemical staining to evaluate the expression of MMP-1, MMP-3, MMP-9 and MMP-13 was performed. Subsequently, the expression level was correlated with metastatic potential, histological grading and overall survival in patients with this neoplasm. In consideration of semi quantitative scoring 64% of chondrosarcoma were scored as positive for MMP-1, 46% for MMP-3, 61% for MMP-9. The specimens had shown no expression of MMP-13. High expression of MMP-9 was associated with better histological differentiation, decreased metastatic potential and favourable overall survival. No correlation was found for expression of MMP-1, MMP-3 or MMP-13. MMP-1, MMP-3 and MMP-9 are expressed in chondrosarcoma. Our findings suggest that the expression of MMP-9 is associated with clinical outcome parameters in chondrosarcoma.Keywords
Funding Information
- AXIS-Forschungsstiftung, Hamburg, Germany
This publication has 37 references indexed in Scilit:
- Preoperative radiographic and histopathologic evaluation of central chondrosarcomaArchives of orthopaedic and trauma surgery, 2013
- Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-upArchives of orthopaedic and trauma surgery, 2012
- Physiology and pathophysiology of matrix metalloproteasesAmino Acids, 2010
- CD44: survival and metastasis in chondrosarcomaOsteoarthritis and Cartilage, 2010
- Expression of integrin-linked kinase and its binding partners in chondrosarcoma: Association with prognostic significanceEuropean Journal of Cancer, 2008
- Tube Travel: The Role of Proteases in Individual and Collective Cancer Cell InvasionCancer Research, 2008
- Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcomaCancer, 2007
- Osteosarcoma, Chondrosarcoma, and Ewing's SarcomaClinical Orthopaedics and Related Research, 2007
- Chondrosarcoma of BoneJournal of Bone and Joint Surgery, 1999
- Bone cancersCancer, 1995